Nestle CEO says weight-loss drugs no threat to coffee business
ZURICH (Reuters) – Nestle sees no threat to its huge coffee business from the rising popularity of weight-loss drugs like Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy, Chief Executive Mark Schneider said…
Novo Nordisk, Lilly see insatiable demand for weight-loss drugs
By Maggie Fick and Bhanvi Satija (Reuters) – Novo Nordisk and Eli Lilly both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years – limited only by…
Weight-loss drug worries add to US restaurants’ weak traffic woes
By Deborah Mary Sophia (Reuters) – Investors will look for signs that U.S. fast-food chains, already contending with inflation-stung consumers preferring to dine at home, will also have to grapple with the…
Exclusive-Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug-sources
By Maggie Fick LONDON (Reuters) – Catalent’s plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk’s weight-loss drug Wegovy as part of the two companies’ expanded supply agreement, two sources…
Strong U.S. demand eases pressure on Novo to show weight-loss drug’s health benefits
By Maggie Fick LONDON (Reuters) – Soaring U.S. demand for Novo Nordisk’s weight-loss drug has reduced the pressure from investors on the company to deliver strong results in its trial to test…
FDA warns about safety risks of tailored weight-loss drugs
(Reuters) – The U.S. Food and Drug Administration (FDA) warned about the safety risks of using compounded or custom-made versions of popular weight-loss drugs such as Wegovy and diabetes drug Ozempic. The…
Weight-loss drug pioneers aim to jump on Wegovy bandwagon
By Jennifer Rigby DUBLIN (Reuters) – Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing treatments are hoping the resulting demand will boost demand for their older,…
Zealand, Boehringer’s drug meets main weight-loss goal in mid-stage trial
By Ludwig Burger FRANKFURT (Reuters) – Zealand Pharma and partner Boehringer Ingelheim said their experimental obesity drug achieved up to 14.9% weight loss after 46 weeks in a mid-stage trial, adding a…
Factbox-New recommendations for weight-loss drugs
By Patrick Wingrove (Reuters) – Novo Nordisk’s Wegovy won U.S. approval in June 2021 with a label that says it can be used for chronic weight management in patients with a body…
U.S. experts recommend weight-loss drugs for obese children
By Bhanvi Satija (Reuters) – The American Academy of Pediatrics (AAP) on Monday recommended use of weight-loss drugs in children ages 12 years or older for treatment of obesity, which impacts about…
Retired New Jersey Doctor Convicted at Trial of Selling Toxic Chemical as Weight-loss Drug
PHILADELPHIA – United States Attorney Jacqueline C. Romero announced that William Merlino, 85, of Mays Landing, NJ, was convicted at trial of selling misbranded drugs online, arising from his scheme to sell…
Man Sentenced to a Year in Federal Prison for Selling Weight-Loss Product Containing Unapproved Additive
CHICAGO — A federal judge in Chicago has sentenced a man to a year in prison for manufacturing and selling a purported weight-loss product containing the unapproved additive 2,4-Dinitrophenol, known as DNP.…
Breaking News
